Concept of a point of care test to detect new oral anticoagulants in urine samples

Thrombosis Journal

Volumn 11, Issue 1, 2013, Pages

  Harenberg, Job ^a   Krämer, Sandra ^a   Du, Shanshan ^a   Weiss, Christel ^a   Krämer, Roland ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Anticoagulation; Apixaban; Coagulation assay; Compliance; Dabigatran; Monitoring; Oral anticoagulant; Renal function; Rivaroxaban; Urine

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR; DABIGATRAN; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN; THROMBIN INHIBITOR;

BLOOD CLOTTING; BLOOD SAMPLING; CREATININE CLEARANCE; DRUG INDICATION; DRUG URINE LEVEL; FIBRINOLYTIC THERAPY; GLOMERULUS FILTRATION; HUMAN; HYDROPHILICITY; KIDNEY FUNCTION; PATIENT COMPLIANCE; POINT OF CARE TESTING; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THROMBOSIS PREVENTION; URINALYSIS; VENOUS THROMBOEMBOLISM;

EID: 84883781182     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-11-15     Document Type: Review

References (24)

1. Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW. Prevention of VTE in orthopedic surgery patients. Chest 2012, 141:e278S-e325S. 10.1378/chest.11-2404, 3278063, 22315265.
2. Roskell NS, Lip GY, Noack H, Clemens A, Plumb JM. Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate. Thromb Haemost 2010, 104:1106-1115. 10.1160/TH10-10-0642, 20967400.
3. Linkins LA, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S, Crother M. Treatment and prevention of heparin-induced thrombocytopenia. Chest 2012, 141:e495S-e530S. 10.1378/chest.11-2303, 3278058, 22315270.
4. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists. Chest 2008, 133:160S-198S. 10.1378/chest.08-0670, 18574265.
5. Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 2010, 123:638-645. e4, 10.1016/j.amjmed.2009.11.025, 20609686.
6. van den Besselaar AM, Péquériaux NC, Ebben M, van der Feest J, de Jong K, Ganzeboom MB, van Ooijen J, Postema F, Witteveen E, van der Meer FJ. Point-of-care monitoring of vitamin k-antagonists: validation of coaguchek xs test strips with international standard thromboplastin. J Clin Pathol 2012, 65:1031-1035. 10.1136/jclinpath-2012-200934, 22859395.
7. Hur M, Kim H, Park CM, La Gioia A, Choi SG, Choi JH, Moon HW, Yun YM. Comparison of international normalized ratio measurement between CoaguChek XS plus and STA-R coagulation analyzers. Biomed Res Int 2013,
8. Garcia-Alamino JM, Ward AM, Alonso-Coello P, Perera R, Bankhead C, Fitzmaurice D, Heneghan CJ. Self-monitoring and self-management of oral anticoagulation. Cochrane Database Syst Rev 2010,
9. Heneghan C, Ward A, Perera R. Self-monitoring trialist collaboration: self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet 2012, 379:322-334. 10.1016/S0140-6736(11)61294-4, 22137798.
10. Kubitza D, Becka M, Mueck W, Halabi A, Maatouk H, Klause N, Lufft V, Wand DD, Philipp T, Bruck H. Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor. Br J Clin Pharmacol 2010, 70:703-712. 10.1111/j.1365-2125.2010.03753.x, 2997310, 21039764.
11. Favaloro EJ, Lippi G, Koutts J. Laboratory testing of anticoagulants: the present and the future. Pathology 2011, 43:682-692. 10.1097/PAT.0b013e32834bf5f4, 22081129.
12. Favaloro EJ, Lippi G. Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against?. Clin Chem Lab Med 2011, 49:755-757.
13. Szelke H, Schübel S, Harenberg J, Krämer R. A fluorescent probe for the quantification of heparin in clinical samples with minimal matrix interference. Chem Commun 2010, 46:1667-1669.
14. Stehle G, Wunder A, Sinn H, Schrenk HH, Harenberg J, Malsch R, Maier-Borst W, Heene DL. Pharmacokinetic properties of LMW-heparin-tyramine fractions with high or low affinity to antithrombin III in the rat. Semin Thromb Hemost 1997, 23:31-37. 10.1055/s-2007-996067, 9156408.
15. Malsch R, Timmermann A, Harenberg J. Capillary electrophoresis of r-hirudin and a polyethylene glycol derivative of r-hirudin (PEG-hirudin). Semin Thromb Hemost 1997, 23:39-43. 10.1055/s-2007-996068, 9156409.
16. De Vries JX, Simon M, Zimmermann R, Harenberg J. Identification of phenprocoumon metabolites in human urine by high-performance liquid chromatography and gas chromatography-mass spectrometry. J Chromatogr 1985, 338:325-334.
17. Harenberg J, Stehle G, Waibel S, Hermann HJ, Eisenhut M, Zimmermann R. Disposition of human fibrinopeptide A in normal and nephrectomized rabbits. Thromb Res 1983, 32:1-13. 10.1016/0049-3848(83)90149-4, 6658706.
18. Harenberg J, Kraemer R. Measurement of the new anticoagulants. Thromb Res 2012, 129(Suppl 1):S106-S113.
19. Harenberg J, Du S, Krämer S, Giese C, Schulze A, Weiss C, Krämer R. Novel methods for assessing oral direct factor Xa and thrombin inhibitors: use of point-of-care testing and urine samples. Semin Thromb Hemost 2013, 39:66-71.
20. Harenberg J, Kraemer R. Direct thrombin inhibitors 2012, International Patent No. PCT/EP2012/002540.
21. Harenberg J, Kraemer R. Direct factor Xa inhibitors 2011, International Patent No. PCT/EP2011/005586.
22. Mahler C, Hermann K, Horne R, Ludt S, Haefeli WE, Szecsenyi J. Assessing reported adherence to pharmacological treatment recommendations. J Eval Clin Pract 2010, 16:574-579.
23. Attema-de Jonge ME, Peeters SY, Franssen EJ. Performance of three point of-care urinalysis test devices for drugs of abuse and therapeutic drugs applied in the emergency department. J Emerg Med 2012, 42:682-691. 10.1016/j.jemermed.2011.01.031, 21911284.
24. Cervinski MA, Lockwood CM, Ferguson AM, Odem RR, Stenman UH, Alfthan H. Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy. Clin Chim Acta 2009, 406:81-85. 10.1016/j.cca.2009.05.018, 19477170.